7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

XORTX Therapeutics
(NASDAQ:XRTX) 

XRTX stock logo

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant pol...

Founded: 2011
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
XORTX Therapeutics Op Cashflow Per Share ttm
202304 202403 202404 -5.22-4.48-3.73-2.98-2.24-1.49-0.750
XORTX Therapeutics Free Cashflow Per Share ttm
202304 202403 202404 -5.25-4.5-3.75-3-2.25-1.5-0.750
XORTX Therapeutics Cash Per Share ttm
202304 202403 202404 00.360.721.091.451.812.172.54
XORTX Therapeutics (GAAP) P/E ratio ttm
202304 202403 202404 -0.95-0.82-0.68-0.54-0.41-0.27-0.140
XORTX Therapeutics P/B ratio ttm
202304 202403 202404 00.170.350.520.690.871.041.22
No extra charts and metrics for this ticker.